Tissue specific diversification, virulence and immune response to Mycobacterium bovis BCG in a patient with an IFN-γ R1 deficiency

Summary: We characterized Mycobacterium bovis BCG isolates found in lung and brain samples from a previously vaccinated patient with IFNγR1 deficiency. The isolates collected displayed distinct genomic and phenotypic features consistent with host adaptation and associated changes in antibiotic susce...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cecilia B. Korol, Shamira J. Shallom, Kriti Arora, Helena I. Boshoff, Alexandra F. Freeman, Alejandra King, Sonia Agrawal, Sean C. Daugherty, Timothy Jancel, Juraj Kabat, Sundar Ganesan, Marina N. Torrero, Elizabeth P. Sampaio, Clifton Barry, Steve M Holland, Hervé Tettelin, Sergio D Rosenzweig, Adrian M. Zelazny
Formato: article
Lenguaje:EN
Publicado: Taylor & Francis Group 2020
Materias:
bcg
Acceso en línea:https://doaj.org/article/c389e6b7ad754220ad0f5defb0a60810
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c389e6b7ad754220ad0f5defb0a60810
record_format dspace
spelling oai:doaj.org-article:c389e6b7ad754220ad0f5defb0a608102021-11-17T14:21:59ZTissue specific diversification, virulence and immune response to Mycobacterium bovis BCG in a patient with an IFN-γ R1 deficiency2150-55942150-560810.1080/21505594.2020.1848108https://doaj.org/article/c389e6b7ad754220ad0f5defb0a608102020-12-01T00:00:00Zhttp://dx.doi.org/10.1080/21505594.2020.1848108https://doaj.org/toc/2150-5594https://doaj.org/toc/2150-5608Summary: We characterized Mycobacterium bovis BCG isolates found in lung and brain samples from a previously vaccinated patient with IFNγR1 deficiency. The isolates collected displayed distinct genomic and phenotypic features consistent with host adaptation and associated changes in antibiotic susceptibility and virulence traits. Background: We report a case of a patient with partial recessive IFNγR1 deficiency who developed disseminated BCG infection after neonatal vaccination (BCG-vaccine). Distinct M. bovis BCG-vaccine derived clinical strains were recovered from the patient’s lungs and brain. Methods: BCG strains were phenotypically (growth, antibiotic susceptibility, lipid) and genetically (whole genome sequencing) characterized. Mycobacteria cell infection models were used to assess apoptosis, necrosis, cytokine release, autophagy, and JAK-STAT signaling. Results: Clinical isolates BCG-brain and BCG-lung showed distinct Rv0667 rpoB mutations conferring high- and low-level rifampin resistance; the latter displayed clofazimine resistance through Rv0678 gene (MarR-like transcriptional regulator) mutations. BCG-brain and BCG-lung showed mutations in fadA2, fadE5, and mymA operon genes, respectively. Lipid profiles revealed reduced levels of PDIM in BCG-brain and BCG-lung and increased TAGs and Mycolic acid components in BCG-lung, compared to parent BCG-vaccine. In vitro infected cells showed that the BCG-lung induced a higher cytokine release, necrosis, and cell-associated bacterial load effect when compared to BCG-brain; conversely, both strains inhibited apoptosis and altered JAK-STAT signaling. Conclusions: During a chronic-disseminated BCG infection, BCG strains can evolve independently at different sites likely due to particular microenvironment features leading to differential antibiotic resistance, virulence traits resulting in dissimilar responses in different host tissues.Cecilia B. KorolShamira J. ShallomKriti AroraHelena I. BoshoffAlexandra F. FreemanAlejandra KingSonia AgrawalSean C. DaughertyTimothy JancelJuraj KabatSundar GanesanMarina N. TorreroElizabeth P. SampaioClifton BarrySteve M HollandHervé TettelinSergio D RosenzweigAdrian M. ZelaznyTaylor & Francis Grouparticletuberculosisbcgantibiotic resistanceimmunodeficiencymendelian susceptibility to mycobacterial diseasesinterferon-γInfectious and parasitic diseasesRC109-216ENVirulence, Vol 11, Iss 1, Pp 1656-1673 (2020)
institution DOAJ
collection DOAJ
language EN
topic tuberculosis
bcg
antibiotic resistance
immunodeficiency
mendelian susceptibility to mycobacterial diseases
interferon-γ
Infectious and parasitic diseases
RC109-216
spellingShingle tuberculosis
bcg
antibiotic resistance
immunodeficiency
mendelian susceptibility to mycobacterial diseases
interferon-γ
Infectious and parasitic diseases
RC109-216
Cecilia B. Korol
Shamira J. Shallom
Kriti Arora
Helena I. Boshoff
Alexandra F. Freeman
Alejandra King
Sonia Agrawal
Sean C. Daugherty
Timothy Jancel
Juraj Kabat
Sundar Ganesan
Marina N. Torrero
Elizabeth P. Sampaio
Clifton Barry
Steve M Holland
Hervé Tettelin
Sergio D Rosenzweig
Adrian M. Zelazny
Tissue specific diversification, virulence and immune response to Mycobacterium bovis BCG in a patient with an IFN-γ R1 deficiency
description Summary: We characterized Mycobacterium bovis BCG isolates found in lung and brain samples from a previously vaccinated patient with IFNγR1 deficiency. The isolates collected displayed distinct genomic and phenotypic features consistent with host adaptation and associated changes in antibiotic susceptibility and virulence traits. Background: We report a case of a patient with partial recessive IFNγR1 deficiency who developed disseminated BCG infection after neonatal vaccination (BCG-vaccine). Distinct M. bovis BCG-vaccine derived clinical strains were recovered from the patient’s lungs and brain. Methods: BCG strains were phenotypically (growth, antibiotic susceptibility, lipid) and genetically (whole genome sequencing) characterized. Mycobacteria cell infection models were used to assess apoptosis, necrosis, cytokine release, autophagy, and JAK-STAT signaling. Results: Clinical isolates BCG-brain and BCG-lung showed distinct Rv0667 rpoB mutations conferring high- and low-level rifampin resistance; the latter displayed clofazimine resistance through Rv0678 gene (MarR-like transcriptional regulator) mutations. BCG-brain and BCG-lung showed mutations in fadA2, fadE5, and mymA operon genes, respectively. Lipid profiles revealed reduced levels of PDIM in BCG-brain and BCG-lung and increased TAGs and Mycolic acid components in BCG-lung, compared to parent BCG-vaccine. In vitro infected cells showed that the BCG-lung induced a higher cytokine release, necrosis, and cell-associated bacterial load effect when compared to BCG-brain; conversely, both strains inhibited apoptosis and altered JAK-STAT signaling. Conclusions: During a chronic-disseminated BCG infection, BCG strains can evolve independently at different sites likely due to particular microenvironment features leading to differential antibiotic resistance, virulence traits resulting in dissimilar responses in different host tissues.
format article
author Cecilia B. Korol
Shamira J. Shallom
Kriti Arora
Helena I. Boshoff
Alexandra F. Freeman
Alejandra King
Sonia Agrawal
Sean C. Daugherty
Timothy Jancel
Juraj Kabat
Sundar Ganesan
Marina N. Torrero
Elizabeth P. Sampaio
Clifton Barry
Steve M Holland
Hervé Tettelin
Sergio D Rosenzweig
Adrian M. Zelazny
author_facet Cecilia B. Korol
Shamira J. Shallom
Kriti Arora
Helena I. Boshoff
Alexandra F. Freeman
Alejandra King
Sonia Agrawal
Sean C. Daugherty
Timothy Jancel
Juraj Kabat
Sundar Ganesan
Marina N. Torrero
Elizabeth P. Sampaio
Clifton Barry
Steve M Holland
Hervé Tettelin
Sergio D Rosenzweig
Adrian M. Zelazny
author_sort Cecilia B. Korol
title Tissue specific diversification, virulence and immune response to Mycobacterium bovis BCG in a patient with an IFN-γ R1 deficiency
title_short Tissue specific diversification, virulence and immune response to Mycobacterium bovis BCG in a patient with an IFN-γ R1 deficiency
title_full Tissue specific diversification, virulence and immune response to Mycobacterium bovis BCG in a patient with an IFN-γ R1 deficiency
title_fullStr Tissue specific diversification, virulence and immune response to Mycobacterium bovis BCG in a patient with an IFN-γ R1 deficiency
title_full_unstemmed Tissue specific diversification, virulence and immune response to Mycobacterium bovis BCG in a patient with an IFN-γ R1 deficiency
title_sort tissue specific diversification, virulence and immune response to mycobacterium bovis bcg in a patient with an ifn-γ r1 deficiency
publisher Taylor & Francis Group
publishDate 2020
url https://doaj.org/article/c389e6b7ad754220ad0f5defb0a60810
work_keys_str_mv AT ceciliabkorol tissuespecificdiversificationvirulenceandimmuneresponsetomycobacteriumbovisbcginapatientwithanifngr1deficiency
AT shamirajshallom tissuespecificdiversificationvirulenceandimmuneresponsetomycobacteriumbovisbcginapatientwithanifngr1deficiency
AT kritiarora tissuespecificdiversificationvirulenceandimmuneresponsetomycobacteriumbovisbcginapatientwithanifngr1deficiency
AT helenaiboshoff tissuespecificdiversificationvirulenceandimmuneresponsetomycobacteriumbovisbcginapatientwithanifngr1deficiency
AT alexandraffreeman tissuespecificdiversificationvirulenceandimmuneresponsetomycobacteriumbovisbcginapatientwithanifngr1deficiency
AT alejandraking tissuespecificdiversificationvirulenceandimmuneresponsetomycobacteriumbovisbcginapatientwithanifngr1deficiency
AT soniaagrawal tissuespecificdiversificationvirulenceandimmuneresponsetomycobacteriumbovisbcginapatientwithanifngr1deficiency
AT seancdaugherty tissuespecificdiversificationvirulenceandimmuneresponsetomycobacteriumbovisbcginapatientwithanifngr1deficiency
AT timothyjancel tissuespecificdiversificationvirulenceandimmuneresponsetomycobacteriumbovisbcginapatientwithanifngr1deficiency
AT jurajkabat tissuespecificdiversificationvirulenceandimmuneresponsetomycobacteriumbovisbcginapatientwithanifngr1deficiency
AT sundarganesan tissuespecificdiversificationvirulenceandimmuneresponsetomycobacteriumbovisbcginapatientwithanifngr1deficiency
AT marinantorrero tissuespecificdiversificationvirulenceandimmuneresponsetomycobacteriumbovisbcginapatientwithanifngr1deficiency
AT elizabethpsampaio tissuespecificdiversificationvirulenceandimmuneresponsetomycobacteriumbovisbcginapatientwithanifngr1deficiency
AT cliftonbarry tissuespecificdiversificationvirulenceandimmuneresponsetomycobacteriumbovisbcginapatientwithanifngr1deficiency
AT stevemholland tissuespecificdiversificationvirulenceandimmuneresponsetomycobacteriumbovisbcginapatientwithanifngr1deficiency
AT hervetettelin tissuespecificdiversificationvirulenceandimmuneresponsetomycobacteriumbovisbcginapatientwithanifngr1deficiency
AT sergiodrosenzweig tissuespecificdiversificationvirulenceandimmuneresponsetomycobacteriumbovisbcginapatientwithanifngr1deficiency
AT adrianmzelazny tissuespecificdiversificationvirulenceandimmuneresponsetomycobacteriumbovisbcginapatientwithanifngr1deficiency
_version_ 1718425443759030272